| Health Care Providers & Services Industry | Healthcare Sector | Jianyu Yang CEO | NYSE Exchange | 206277105 CUSIP |
| CN Country | 595 Employees | 29 Jan 2016 Last Dividend | 16 Jan 2014 Last Split | - IPO Date |
Concord Medical Services Holdings Limited, established in 1997 and headquartered in Beijing, the People's Republic of China, specializes in operating a network of radiotherapy and diagnostic imaging centers. Through its subsidiaries, the company services the healthcare needs in two main segments: Network and Hospital. It focuses on delivering advanced cancer treatment solutions and diagnostic services across its platforms, leveraging modern technology and clinical research to improve patient outcomes. The company also extends its expertise to clinical support, equipment leasing, management services, and operates specialty cancer hospitals providing a comprehensive range of medical services.
These are cornerstone treatments in cancer therapy, focusing on the use of high-energy rays to target and destroy cancer cells. Concord Medical offers the latest technology in linear accelerators for precise treatment delivery.
A cutting-edge cancer treatment that uses protons rather than x-rays to treat cancer. The proton therapy system allows for more precise targeting of tumor sites, minimizing damage to surrounding healthy tissues.
This is a form of radiosurgery used to treat brain tumors, arteriovenous malformations, and other brain disorders. It's a minimally invasive procedure that offers high precision in targeting small areas within the brain.
Concord Medical provides a wide range of diagnostic imaging services, including positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI) scanners. These technologies are essential for the accurate diagnosis and treatment planning of various diseases.
The company aids in the development of treatment protocols, organizes joint diagnosis meetings, and supports clinical research to enhance treatment outcomes. Additionally, it assists in the recruitment and compensation determination for doctors and medical staff.
Offering radiotherapy and diagnostic equipment leasing, alongside management services, Concord Medical provides hospitals and healthcare facilities with access to state-of-the-art medical technology without the need for significant upfront investments.
These services are targeted towards hospitals seeking to offer high-end cancer treatment options, including specialized proton therapy, enhancing their capabilities in providing comprehensive cancer care.
Leveraging technology to bridge the gap in healthcare access, the company offers teleconsultation services and medical information technology solutions to improve patient care and operational efficiency.
Concord Medical operates specialty cancer hospitals that provide a full spectrum of services, from radiation therapy, diagnostic imaging, and laboratory tests to inpatient care and nursing services, focusing on delivering holistic cancer treatment.